← back to search

Jie Zhu

Karolinska University Hospital · SE
Area of research
Neurology · Pathology and Forensic Medicine
Research interest
Research interests include Peripheral Neuropathies and Disorders, Neuroinflammation and Neurodegeneration Mechanisms, Multiple Sclerosis Research Studies, and Cytokine Signaling Pathways and Interactions.
h-index
48
citations
9,471
works
268
NIH funding
primary concept
email

Recent publications

Peripheral blood amyloid-β involved in the pathogenesis of Alzheimer’s disease via impacting on peripheral innate immune cells
Journal of Neuroinflammation 2024cited by 43position: lastdoi
Phospholipase D, a Novel Therapeutic Target Contributes to the Pathogenesis of Neurodegenerative and Neuroimmune Diseases.
2024cited by 4position: contributordoi
Resistant Dextrin Preexistence and Fate: Preparation, Physicochemical and Functional Properties, Physiological Activity, and Food Applications: A Review
Food Reviews International 2024cited by 2position: lastdoi
Glymphatic system: an emerging therapeutic approach for neurological disorders
Frontiers in Molecular Neuroscience 2023cited by 76position: lastdoi
FGF/FGFR system in the central nervous system demyelinating disease: Recent progress and implications for multiple sclerosis
CNS Neuroscience & Therapeutics 2023cited by 23position: middledoi
Current non-invasive strategies for brain drug delivery: overcoming blood–brain barrier transport
Molecular Biology Reports 2023cited by 18position: lastdoi
Discrepancy in clinical and laboratory profiles of NMOSD patients between AQP4 antibody positive and negative: can NMOSD be diagnosed without AQP4 antibody?
Clinical & Experimental Immunology 2023cited by 12position: lastdoi
Impact of Anti-amyloid-β Monoclonal Antibodies on the Pathology and Clinical Profile of Alzheimer’s Disease: A Focus on Aducanumab and Lecanemab
Frontiers in Aging Neuroscience 2022cited by 257position: lastdoi
Progress in treatment of neuromyelitis optica spectrum disorders (NMOSD): Novel insights into therapeutic possibilities in NMOSD
CNS Neuroscience & Therapeutics 2022cited by 49position: lastdoi
Levetiracetam alleviates cognitive decline in Alzheimer’s disease animal model by ameliorating the dysfunction of the neuronal network
Frontiers in Aging Neuroscience 2022cited by 37position: middledoi
Increased oxidative stress contributes to impaired peripheral CD56dimCD57+ NK cells from patients with systemic lupus erythematosus
Arthritis Research & Therapy 2022cited by 33position: middledoi
Impact of disease-modifying therapy on dendritic cells and exploring their immunotherapeutic potential in multiple sclerosis.
2022cited by 17position: contributordoi
Role of Adaptive Immune and Impacts of Risk Factors on Adaptive Immune in Alzheimer's Disease: Are Immunotherapies Effective or Off-Target?
2022cited by 10position: contributordoi
PD-1/PD-L1 Axis as a Potential Therapeutic Target for Multiple Sclerosis: A T Cell Perspective
Frontiers in Cellular Neuroscience 2021cited by 44position: middledoi
Role of Toll-Like Receptors in Neuroimmune Diseases: Therapeutic Targets and Problems
Frontiers in Immunology 2021cited by 39position: middledoi
Potential role of BAY11-7082, a NF-κB blocker inhibiting experimental autoimmune encephalomyelitis in C57BL/6J mice via declining NLRP3 inflammasomes
Clinical & Experimental Immunology 2021cited by 25position: lastdoi
The brain mechanism of awakening dysfunction in children with primary nocturnal enuresis based on PVT-NAc neural pathway: a resting-state fMRI study
Scientific Reports 2021cited by 6position: middledoi
Inflammatory Role of TLR-MyD88 Signaling in Multiple Sclerosis
Frontiers in Molecular Neuroscience 2020cited by 143position: middledoi
Characteristic CT findings distinguishing 2019 novel coronavirus disease (COVID-19) from influenza pneumonia
European Radiology 2020cited by 131position: middledoi
Transitional B cells involved in autoimmunity and their impact on neuroimmunological diseases
Journal of Translational Medicine 2020cited by 108position: middledoi
Role of Resolvins in the Inflammatory Resolution of Neurological Diseases
Frontiers in Pharmacology 2020cited by 76position: middledoi
Axonal variants of Guillain–Barré syndrome: an update
Journal of Neurology 2020cited by 69position: middledoi
Target Dysbiosis of Gut Microbes as a Future Therapeutic Manipulation in Alzheimer’s Disease
Frontiers in Aging Neuroscience 2020cited by 60position: lastdoi
Regulation of microglia by glutamate and its signal pathway in neurodegenerative diseases
Drug Discovery Today 2020cited by 48position: middledoi
Elevated serum interleukin-39 levels in patients with neuromyelitis optica spectrum disorders correlated with disease severity
Multiple Sclerosis and Related Disorders 2020cited by 21position: middledoi
Roles of Neuropeptide Y in Neurodegenerative and Neuroimmune Diseases
Frontiers in Neuroscience 2019cited by 114position: middledoi
Autologous Mesenchymal Stem Cell Transplantation in Multiple Sclerosis: A Meta-Analysis.
2019cited by 18position: contributordoi
The roles of macrophages and microglia in multiple sclerosis and experimental autoimmune encephalomyelitis
Journal of Neuroimmunology 2018cited by 309position: middledoi
Gut Microbiota in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis: Current Applications and Future Perspectives
Mediators of Inflammation 2018cited by 155position: middledoi
Role of Inflammasomes in Neuroimmune and Neurodegenerative Diseases: A Systematic Review
Mediators of Inflammation 2018cited by 77position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Tao Jin · Jiangsu University11 papers (2014–2023)Fengna Chu · Karolinska University Hospital10 papers (2018–2024)Chao Zheng · Wenzhou Medical University7 papers (2017–2021)Mingchao Shi · Jilin University6 papers (2018–2024)Xiangyu Zheng · China University of Petroleum, Beijing5 papers (2013–2022)Jinming Han · Allen Institute for Brain Science5 papers (2015–2021)Donghui Shen · Jilin University5 papers (2018–2021)Kangding Liu · Jilin University4 papers (2019–2023)Li Cui · National Natural Science Foundation of China4 papers (2018–2021)Xiujuan Wu · Jilin University4 papers (2019–2022) · 4 papers (2019–2024)Feiqi Zhu · Shenzhen Third People’s Hospital3 papers (2020–2024)Shan Liu · New York University3 papers (2019–2021)Hongliang Zhang · University of Oxford3 papers (2013–2020)Yue Lang · Shanghai University3 papers (2018–2021)Chunrong Li · Guangdong University of Technology3 papers (2019–2020)Jingtao Chen · Sun Yat-sen University Cancer Center2 papers (2017–2020)Weiguanliu Zhang · Case Western Reserve University2 papers (2018–2021)Haixia Li · Hubei University of Medicine2 papers (2021–2021)Caiyun Liu · Nanchang University2 papers (2017–2020)